2021 Global Market Outlook - Q4 Update: Growing pains
The COVID-19 delta variant, inflation and central bank tapering are unnerving investors. We expect the pandemic-recovery trade to resume as inflation subsides, infection rates decline, and tapering turns out to not equal tightening. The outlook favors equities over bonds, the value factor over the growth factor and non-U.S. over U.S. stocks.
We serve financial advisors
Introducing RISERI, an advisor-centric experience providing premium investment and business solutions.
We serve institutional investors
Discover investment possibilities that support your long-term goals and open up a world of potential.
FACTOR
The big investor advantage
Many of the world’s most demanding investors have turned to Russell Investments to guide them through the opportunity and uncertainty of investing. With Russell Investments, a big investor advantage is now yours.
RECENT INSIGHTS
Hear from our experts on the issues our clients care about
We are a leading investment solutions partner, dedicated to improving people's financial security.
Our approach
Put a selection of the world's leading investment managers to work for you.
Our history
Innovation has been part of our DNA since our story began in 1936.
Diversity
We are proud to support equality and diversity in the workplace.
Corporate responsibility
We embody a strong commitment to exceptional standards of corporate responsibility.
Compliance with U.S. Executive Order 13959
On June 3, 2021 President Biden signed an Executive Order to further address the ongoing national emergency declared in E.O. 13959 “Addressing the Threat from Securities Investments that Finance Certain Companies of the People's Republic of China” and related FAQs. The E.O. addresses the threat posed by the military-industrial complex of the People's Republic of China (PRC) and its involvement in military, intelligence, and security research and development programs, and weapons and related equipment production under the PRC's Military-Civil Fusion strategy. The E.O of June 3, 2021 amends E.O 13959 and restricts the purchase or sale of any publicly traded securities, or any publicly traded securities that are derivative of such securities or are designed to provide investment exposure to such securities, of any person listed in the Annex to the order. We have taken steps as required to comply with the Order to the best of our knowledge and belief. We continue to monitor this matter to assess any potential impact or actions needed, as facts and circumstances continue to evolve.